Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 213
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #233: FDA Floats Ibogaine Trial Design; Compass Talks Pricing; Potential LSD, Psilocybin Brand Names
Kenneth Tupper, PhD: Harm Reduction, Drug Education, Canadian Ayahuasca, and Psychedelic Public Health
Weekly Psychedelic Policy Briefing: October 5, 2026
Podcast: Oregon Backtracks on Fee Hike, California Funds Psychedelic Research, DEA Moves to Schedule 5 Tryptamines
Psychedelic Churches Need Psychedelic Seminaries
Psychedelic Science Leader Eleusis to Become Public Company in Merger with...
Awakn Life Sciences Signs MOU with Maps
Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical...
Two thirds of physicians surveyed believe psilocybin therapy has potential benefit...
Psygen Receives Dealer’s Licence from Health Canada
Red Light Holland to Collaborate with Advocacy Group, Psychedelic Medicine Alliance...
Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations...
Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Psychedelics Today
BetterLife Obtains Positive In Vivo Oral Bioavailability, Food Effect and Pharmacokinetics...
Entheon Biomedical Corp. Files Preliminary Shelf Prospectus
Load more